ARCHIVES

In Brief: Forel Retires As Dana-Farber Director, Successor Is David Livingston; Benacerraf Plans Departure

This article is from The Cancer Letter archive.

Vol. 17 No. 27 | July 5, 1991

Download PDF Visit The Full Archive

Related Articles

In Brief: DeVita, FDA Chief Help Kill California Bill Legalizing Laetrile Wit committee Testimony

August 26, 1977

NCI Moratorium On New OIG Applications; P01 Funding Steadily Drops

May 1, 1992

HPV DNA Testing Reduced Cervical Cancer Precursors

September 24, 2010

Some NCI Advisors Tell GAO Congress “Jumped The Gun” In Creating Cancer Control Program

October 26, 1979

Study Finds Gene Expression Test Predicts Stage I or II Recurrence

August 30, 2013

“Treatment INDs” Seen As Major Threat To Clinical Trials

August 21, 1987